U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C27H30N4O4
Molecular Weight 474.5515
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SATERINONE

SMILES

COC1=C(C=CC=C1)N2CCN(CC(O)COC3=CC=C(C=C3)C4=C(C)NC(=O)C(=C4)C#N)CC2

InChI

InChIKey=KLEKLDFUYOZELG-UHFFFAOYSA-N
InChI=1S/C27H30N4O4/c1-19-24(15-21(16-28)27(33)29-19)20-7-9-23(10-8-20)35-18-22(32)17-30-11-13-31(14-12-30)25-5-3-4-6-26(25)34-2/h3-10,15,22,32H,11-14,17-18H2,1-2H3,(H,29,33)

HIDE SMILES / InChI

Molecular Formula C27H30N4O4
Molecular Weight 474.5515
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Saterinone, a dual-action drug combines both alpha-1 blocking vasodilatory property and phosphodiesterase III (PDE III) inhibition--mediated inotropism. PDE III inhibitors are well established in the acute intravenous treatment of patients with decompensated chronic congestive heart failure. Saterinone was demonstrated to be a safe and potent drug on short-term application without major changes in myocardial oxygen consumption. Saterinone was studied in phase II trials in Germany for the treatment of heart failure. However, the development of this drug has been discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
Positive inotropic and vasodilatory actions of saterinone in vivo.
1988 Sep
Pharmacological properties of the positive inotropic and alpha 1-adrenoceptor blocking agent saterinone.
1988 Sep
Pharmacokinetics and hemodynamic effects of the phosphodiesterase III inhibitor saterinone in patients with chronic heart failure.
2003 Oct

Sample Use Guides

Saterinone was given by intravenous infusion for 24 hours at a rate of 1.5 microg/kg per min
Route of Administration: Intravenous
Substance Class Chemical
Created
by admin
on Sat Dec 16 17:31:40 GMT 2023
Edited
by admin
on Sat Dec 16 17:31:40 GMT 2023
Record UNII
W4P85FO7GS
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SATERINONE
INN  
INN  
Official Name English
saterinone [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C744
Created by admin on Sat Dec 16 17:31:40 GMT 2023 , Edited by admin on Sat Dec 16 17:31:40 GMT 2023
Code System Code Type Description
MESH
C058572
Created by admin on Sat Dec 16 17:31:40 GMT 2023 , Edited by admin on Sat Dec 16 17:31:40 GMT 2023
PRIMARY
SMS_ID
100000084099
Created by admin on Sat Dec 16 17:31:40 GMT 2023 , Edited by admin on Sat Dec 16 17:31:40 GMT 2023
PRIMARY
FDA UNII
W4P85FO7GS
Created by admin on Sat Dec 16 17:31:40 GMT 2023 , Edited by admin on Sat Dec 16 17:31:40 GMT 2023
PRIMARY
PUBCHEM
65874
Created by admin on Sat Dec 16 17:31:40 GMT 2023 , Edited by admin on Sat Dec 16 17:31:40 GMT 2023
PRIMARY
CAS
102669-89-6
Created by admin on Sat Dec 16 17:31:40 GMT 2023 , Edited by admin on Sat Dec 16 17:31:40 GMT 2023
PRIMARY
ChEMBL
CHEMBL2030222
Created by admin on Sat Dec 16 17:31:40 GMT 2023 , Edited by admin on Sat Dec 16 17:31:40 GMT 2023
PRIMARY
NCI_THESAURUS
C74348
Created by admin on Sat Dec 16 17:31:40 GMT 2023 , Edited by admin on Sat Dec 16 17:31:40 GMT 2023
PRIMARY
EPA CompTox
DTXSID30883106
Created by admin on Sat Dec 16 17:31:40 GMT 2023 , Edited by admin on Sat Dec 16 17:31:40 GMT 2023
PRIMARY
EVMPD
SUB10457MIG
Created by admin on Sat Dec 16 17:31:40 GMT 2023 , Edited by admin on Sat Dec 16 17:31:40 GMT 2023
PRIMARY
INN
5997
Created by admin on Sat Dec 16 17:31:40 GMT 2023 , Edited by admin on Sat Dec 16 17:31:40 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY